XML 15 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Expenses:    
Research and development $ 4,763 $ 81,076
Selling, general and administrative 178,516 149,623
Total expenses (183,279) (230,699)
Loss from operations (183,279) (230,699)
Net loss $ (183,279) $ (230,699)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ (0.01)
Weighted-average number of common shares outstanding - basic and diluted (in shares) 45,572,568 45,572,568